XML 147 R132.htm IDEA: XBRL DOCUMENT v3.23.4
First time adoption of IFRS - Balance Sheet (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Jan. 01, 2022
Dec. 31, 2021
Current assets          
Cash and cash equivalents $ 43,732 $ 42 $ 693 $ 955 $ 955
Trade and other receivables 20,881 53      
Prepayments and other current assets 1,338 201   340  
Total current assets 88,958 296   1,295  
Non-current assets          
Investments   268,909   265,156  
Prepayments and other non-current assets   986   187  
Total non-current assets 1,261,777 269,895   265,343  
Total assets 1,350,735 270,191   266,638  
Current liabilities          
Trade and other payables 63,754 927   604  
Loans and borrowings 42,545 786      
Other financial liabilities 89,910 16,519      
Deferred liabilities 2,437 7,239      
Deferred underwriting discount 7,280 9,280      
Total current liabilities 226,059 18,232   604  
Non-current liabilities          
Derivative financial liability   7,443   8,440  
Other financial liabilities 135,746 264,477   253,530  
Total non-current liabilities 763,448 271,920   261,970  
Total liabilities 989,507 290,152   262,574  
Net assets 361,228 (19,961)   4,064  
Equity          
Ordinary shares   1   1  
Additional paid-in capital 1,236 969   24  
(Accumulated deficit) / retained earnings (53,194) (20,931)   4,039  
Total equity $ 361,228 (19,961) $ (6,984) 4,064 $ 4,062
Total liabilities, class A ordinary shares subject to possible redemption, and equity   270,191   266,638  
US GAAP          
Current assets          
Cash and cash equivalents   42   955  
Trade and other receivables   53      
Prepayments and other current assets   201   340  
Total current assets   296   1,295  
Non-current assets          
Investments   268,909   265,156  
Prepayments and other non-current assets   986   187  
Total non-current assets   269,895   265,343  
Total assets   270,191   266,638  
Current liabilities          
Trade and other payables   927   604  
Loans and borrowings   786      
Deferred liabilities   7,239      
Deferred underwriting discount   9,280      
Total current liabilities   18,232   604  
Non-current liabilities          
Derivative financial liability   7,443   8,440  
Deferred underwriting discount       9,280  
Total non-current liabilities   7,443   17,720  
Total liabilities   25,675   18,324  
Net assets   244,516   248,314  
Class A ordinary shares subject to possible redemption,   268,909   265,148  
Equity          
Ordinary shares   1   1  
(Accumulated deficit) / retained earnings   (24,394)   (16,835)  
Total equity   (24,393)   (16,834)  
Total liabilities, class A ordinary shares subject to possible redemption, and equity   270,191   266,638  
Effect of transition to IFRS          
Current liabilities          
Other financial liabilities   16,519      
Deferred liabilities   (7,239)      
Deferred underwriting discount   (9,280)      
Non-current liabilities          
Other financial liabilities   264,477   253,530  
Deferred underwriting discount       (9,280)  
Total non-current liabilities   264,477   244,250  
Total liabilities   264,477   244,250  
Net assets   (264,477)   (244,250)  
Class A ordinary shares subject to possible redemption,   (268,909)   (265,148)  
Equity          
Additional paid-in capital   969   24  
(Accumulated deficit) / retained earnings   3,463   20,874  
Total equity   $ 4,432   $ 20,898